Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies...
Read moreSchrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies...
Read moreAnnual Revenue
$170.3M
Schrodinger's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 45M. Over the last four quarters, Schrodinger's revenue has decreased by 19.9%. Specifically, in Q3 2022's revenue was $37M; in Q2 2022, it was $38.5M; in Q1 2022, it was $48.7M; in Q4 2021, Schrodinger's revenue was $46.2M.